Introduction Semaglutide Has emerged as a groundbreaking treatment option for those struggling with type 2 diabetes, obesity, and cardiovascular risk. As part of the GLP-1 receptor agonist class, Semaglutide mimics the actions of a naturally occurring hormone in the body, glucagon-like peptide-1 (GLP-1), which plays a vital role in regulating https://trentonahpxc.bligblogging.com/32093164/semaglutide-a-breakthrough-treatment-for-diabetes-weight-loss-and-cardiovascular-health